Literature DB >> 22987042

Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.

Ji Won Um1, Stephen M Strittmatter.   

Abstract

Alzheimer disease (AD) is the most prevalent cause of dementia. Amyloid-β (Aβ) oligomers are potent synaptotoxins thought to mediate AD-related phenotypes. Cellular prion protein (PrP(C)) has been identified as a high-affinity receptor for Aβ oligomers. Herein, we review the functional consequences of Aβ oligomer binding to PrP(C) on the neuronal surface. We highlight recent evidence that Fyn kinase mediates signal transduction downstream of the PrP(C)-Aβ oligomer complex. These studies suggest that PrP(C) has a central role in AD pathogenesis and may provide a target for therapeutic intervention in AD.

Entities:  

Keywords:  Alzheimer disease; Fyn kinase; PrpC; cellular prion protein; prion

Mesh:

Substances:

Year:  2012        PMID: 22987042      PMCID: PMC3609048          DOI: 10.4161/pri.22212

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  50 in total

Review 1.  Src kinases: a hub for NMDA receptor regulation.

Authors:  Michael W Salter; Lorraine V Kalia
Journal:  Nat Rev Neurosci       Date:  2004-04       Impact factor: 34.870

2.  LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.

Authors:  Sha Mi; Xinhua Lee; Zhaohui Shao; Greg Thill; Benxiu Ji; Jane Relton; Melissa Levesque; Norm Allaire; Steve Perrin; Bryan Sands; Thomas Crowell; Richard L Cate; John M McCoy; R Blake Pepinsky
Journal:  Nat Neurosci       Date:  2004-02-15       Impact factor: 24.884

3.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

Review 4.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

Review 5.  Prion protein biology.

Authors:  S B Prusiner; M R Scott; S J DeArmond; F E Cohen
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

6.  A tail of two src's: mutatis mutandis.

Authors:  T Hunter
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

7.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Quantitative assessment of cortical synaptic density in Alzheimer's disease.

Authors:  S W Scheff; S T DeKosky; D A Price
Journal:  Neurobiol Aging       Date:  1990 Jan-Feb       Impact factor: 4.673

View more
  45 in total

1.  Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer's Disease Cell Model via Upregulation of MicroRNA-9.

Authors:  Shaoheng Li; Yuhui Yan; Yanan Jiao; Zhong Gao; Yang Xia; Liang Kong; Yingjia Yao; Zhenyu Tao; Jie Song; Yaping Yan; Guangxian Zhang; Jingxian Yang
Journal:  J Mol Neurosci       Date:  2016-07-09       Impact factor: 3.444

2.  Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.

Authors:  Ji Won Um; Adam C Kaufman; Mikhail Kostylev; Jacqueline K Heiss; Massimiliano Stagi; Hideyuki Takahashi; Meghan E Kerrisk; Alexander Vortmeyer; Thomas Wisniewski; Anthony J Koleske; Erik C Gunther; Haakon B Nygaard; Stephen M Strittmatter
Journal:  Neuron       Date:  2013-09-04       Impact factor: 17.173

3.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

4.  Posttranslational modification impact on the mechanism by which amyloid-β induces synaptic dysfunction.

Authors:  Katarzyna M Grochowska; PingAn Yuanxiang; Julia Bär; Rajeev Raman; Gemma Brugal; Giriraj Sahu; Michaela Schweizer; Arthur Bikbaev; Stephan Schilling; Hans-Ulrich Demuth; Michael R Kreutz
Journal:  EMBO Rep       Date:  2017-04-18       Impact factor: 8.807

Review 5.  The potential role of rho GTPases in Alzheimer's disease pathogenesis.

Authors:  Silvia Bolognin; Erika Lorenzetto; Giovanni Diana; Mario Buffelli
Journal:  Mol Neurobiol       Date:  2014-01-23       Impact factor: 5.590

6.  Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).

Authors:  Laura T Haas; Mikhail A Kostylev; Stephen M Strittmatter
Journal:  J Biol Chem       Date:  2014-08-22       Impact factor: 5.157

Review 7.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 8.  Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

9.  Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.

Authors:  C Vergara; L Ordóñez-Gutiérrez; F Wandosell; I Ferrer; J A del Río; R Gavín
Journal:  Mol Neurobiol       Date:  2014-06-26       Impact factor: 5.590

10.  Plasma prion protein concentration and progression of Alzheimer disease.

Authors:  Christian Schmidt; Harry Becker; Christoph Peter; Katharina Lange; Tim Friede; Inga Zerr
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.